Annals of Oncology

News:

Cheap drugs? Part 3: Bush continues Clinton policy on AIDS drugs but...
Ann Oncol 12: 577.
[PDF] [Request Permissions]

All is not well in France's medical research
Ann Oncol 12: 577.
[PDF] [Request Permissions]

Even in Switzerland... the cowboy strikes again
Ann Oncol 12: 577-578.
[PDF] [Request Permissions]

Italian expert committee reports on uranium waste... and the wastebasket is already full of newspapers
Ann Oncol 12: 578.
[PDF] [Request Permissions]

Cheap drugs? Part 4: Blair sides with industry or simply protects intellectual property?
Ann Oncol 12: 578-579.
[PDF] [Request Permissions]

European Council moves to encourage research
Ann Oncol 12: 579.
[PDF] [Request Permissions]

The virtual supercomputer: Science-fiction becomes a reality against cancer
Ann Oncol 12: 579.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 12: 579-581.
[PDF] [Request Permissions]

Book reviews:

A. L. Harris

Book review
Ann Oncol 12: 582.
[PDF] [Request Permissions]

P. H. M. de Mulder

Book review
Ann Oncol 12: 726.
[PDF] [Request Permissions]

Editorials:

S. Aebi and M. Castiglione-Gertsch

High-dose chemotherapy for ovarian cancer: Are we ready to go?
Ann Oncol 12: 583-584.
[PDF] [Request Permissions]

T. Berghmans, M. Paesmans, and J. P. Sculier

The role of cisplatin in the treatment of small-cell lung cancer?
Ann Oncol 12: 585-586.
[PDF] [Request Permissions]

Reviews:

V. de Haas, C.E. van der Schoot, and H. van den Berg

Risk assessment in ALL in children: A focus on PCR-based techniques for MRD detection
Ann Oncol 12: 587-592.
[PDF] [Request Permissions]

E. D. Razis and G. Fountzilas

Paclitaxel: Epirubicin in metastatic breast cancer — a review
Ann Oncol 12: 593-598.
[Abstract] [PDF] [Request Permissions]

Original articles:

W. Kern, B. Beckert, N. Lang, J. Stemmler, M. Beykirch, J. Stein, E. Goecke, T. Waggershauser, J. Braess, A. Schalhorn, and W. Hiddemann

Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer
Ann Oncol 12: 599-603.
[Abstract] [PDF] [Request Permissions]

M. A. Villalona-Calero, J. L. Blum, S. E. Jones, S. Diab, R. Elledge, P. Khoury, D.Von Hoff, M. Kraynak, J. Moczygemba, P. Kromelis, T. Griffin, and E. K. Rowinsky

A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients
Ann Oncol 12: 605-614.
[Abstract] [PDF] [Request Permissions]

F. Cardoso, A. Di Leo, D. Larsimont, D. Gancberg, G. Rouas, S. Dolci, F. Ferreira, M. Paesmans, and M. Piccart

Evaluation of HER2, p53, bcl-2, topoisomerase II-, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes
Ann Oncol 12: 615-620.
[Abstract] [PDF] [Request Permissions]

F. Di Raimondo, R. Giustolisi, S. Lerner, E. Cacciola, S. O'Brien, H. Kantarjian, and M. I Keating

Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine
Ann Oncol 12: 621-625.
[Abstract] [PDF] [Request Permissions]

S. R. Alberts, C. Erlichman, J. Sloan, S. H. Okuno, P. A. Burch, J. Rubin, H. C. Pitot, R. M. Goldberg, A. A. Adjei, P. J. Atherton, and S. H. Kaufmann

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks
Ann Oncol 12: 627-631.
[Abstract] [PDF] [Request Permissions]

A. B. Kornblith, J. E. Herndon ll, E. Zuckerman, P. A. Godley, D. Savarese, N. J. Vogelzang, and J. C. Holland

The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study
Ann Oncol 12: 633-641.
[Abstract] [PDF] [Request Permissions]

T. Petit, C. Georges, G.-M. Jung, C. Borel, G. Bronner, H. Flesch, G. Massard, M. Velten, P. Haegele, and S. Schraub

Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma
Ann Oncol 12: 643-646.
[Abstract] [PDF] [Request Permissions]

F. R. Hirsch, K. Østerlind, N. Jeppesen, P. Dombernowsky, S. Ingeberg, P. Grundtvig Sorensen, C. Kristensen, and H. H. Hansen

Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients
Ann Oncol 12: 647-653.
[Abstract] [PDF] [Request Permissions]

J. Tate, T. Olencki, J. Finke, K. Kottke-Marchant, L. A. Rybicki, and R.M. Bukowski

Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effects
Ann Oncol 12: 655-659.
[Abstract] [PDF] [Request Permissions]

P. Borchmann, R. Schnell, R. Knippertz, J. O. Staak, G. M. Camboni, A. Bernareggi, K. Hübel, P. Staib, A. Schulz, V. Diehl, and A. Engert

Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma
Ann Oncol 12: 661-667.
[Abstract] [PDF] [Request Permissions]

G. Rosati, A. Rossi, A. Tucci, C. Pizza, and L. Manzione

Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer
Ann Oncol 12: 669-674.
[Abstract] [PDF] [Request Permissions]

C. Louvet, T. André, P. Hammel, F. Selle, B. Landi, S. Cattan, M. Fonck, M. Flesch, P. Colin, J. Balosso, P. Ruszniewski, and A. de Gramont

Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
Ann Oncol 12: 675-679.
[Abstract] [PDF] [Request Permissions]

D. R. Penberthy, T. A. Rich, C. H. Shelton, III, R. Adams, J. S. Minasi, and R. S. Jones

A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer
Ann Oncol 12: 681-684.
[Abstract] [PDF] [Request Permissions]

J.-C. Gazet, H. T. Ford, R. Gray, C. McConkey, R. Sutcliffe, J. Quilliam, V. Makinde, S. Lowndes, and R. C. Coombes

Estrogen-receptor-directed neoadjuvant therapy for breast cancer: Results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy
Ann Oncol 12: 685-691.
[Abstract] [PDF] [Request Permissions]

J. A. Ledermann, R. Herd, D. Maraninchi, P. Viens, M. Buclon, T. Philip, H. Cure, J.-P. Lotz, F. Chauvin, P. Ferrante, G. Rosti, and on behalf of the Solid Tumour Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
Ann Oncol 12: 693-699.
[Abstract] [PDF] [Request Permissions]

E. Galanis, R. Goldberg, J. Reid, P. Atherton, J. Sloan, H. Pitot, J. Rubin, A. A. Adjei, P. Burch, S. L. Safgren, T. E. Witzig, M. M. Ames, and C. Erlichman

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd)
Ann Oncol 12: 701-707.
[Abstract] [PDF] [Request Permissions]

W. Scheithauer, G. V. Kornek, B. Schuell, H. Ulrich-Pur, M. Penz, M. Raderer, F. Lang, B. Schneeweiss, A. Lenauer, and D. Depisch

Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy
Ann Oncol 12: 709-714.
[Abstract] [PDF] [Request Permissions]

Clinical cases:

A. Bamias, G. Baltayiannis, S. Kamina, M. Fatouros, E. Lymperopoulos, N. Agnanti, E. Tsianos, and N. Pavlidis

Rectal metastases from lobular carcinoma of the breast: Report of a case and literature review
Ann Oncol 12: 715-718.
[Abstract] [PDF] [Request Permissions]

M. Sandherr, C. von Schilling, T. Link, K. Stock, N. von Bubnoff, C. Peschel, and N. Avril

Pitfalls in imaging Hodgkin's disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose
Ann Oncol 12: 719-722.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

J. Zgajnar, W. Gatzemeier, and A. Costa

Will the sentinel lymph node (SLN) stand a second time — SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure
Ann Oncol 12: 723.
[PDF] [Request Permissions]

B. Schnetzler, N. Popova, C. Collao Lamb, and A. P. Sappino

Coronary spasm induced by capecitabine
Ann Oncol 12: 723-724.
[PDF] [Request Permissions]

G. Curigliano, G. Ferretti, M. Colleoni, E. Marrocco, G. Peruzzotti, C. De Cicco, G. Paganelli, and A. Goldhirsch

Bone scan had no role in the staging of 765 consecutive operable T_1–2N_0–1 breast cancer patients without skeletal symptoms
Ann Oncol 12: 724-725.
[PDF] [Request Permissions]

Advertisements in this issue:

ASCO
Ann Oncol 12: 727.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting announcements
Ann Oncol 12: 728.
[PDF] [Request Permissions]

ESMO application for membership
Ann Oncol 12: 729.
[PDF] [Request Permissions]

Novartis
Ann Oncol 12: 730.
[PDF] [Request Permissions]

Novartis
Ann Oncol 12: 731.
[PDF] [Request Permissions]

Aventis Pharmaceuticals
Ann Oncol 12: 732-734.
[PDF] [Request Permissions]

Fred H. Menko, Hans Vasen, and Henry Lynch

Kluwer Academic Publishers: Familial Cancer
Ann Oncol 12: 735.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.